HeartSciences (HSCS) Change in Inventory (2021 - 2026)
HeartSciences (HSCS) posted quarterly Change in Inventory of -$1656.0 for Q2 2026, up 11.91% year-on-year from -$1479.7 in Q2 2025, and down 121.29% on a QoQ basis from $7778.0 in Q4 2025.
HeartSciences (HSCS) Change in Inventory (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Change in Inventory for 6 consecutive years, with -$1656.0 the latest figure, recorded in Q2 2026.
- Quarterly Change in Inventory rose 11.91% year-over-year to -$1656.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3482.0 (down 83.49% YoY) and the FY2026 annual result came in at $5362.0, down 74.57% from the prior year.
- Change in Inventory retreated to -$1656.0 in Q2 2026 per HSCS's latest filing, from $7778.0 in the prior quarter.
- Over the last five years, Change in Inventory for HSCS reached as high as $13860.0 in Q3 2024 and fell as low as -$41099.0 in Q2 2024.
- A 5-year average of -$2612.0 and a median of -$760.0 in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory surged 110.49% — and 2024, when it slumped 7372.55%.
- Year by year, Change in Inventory stood at $3530.0 in 2022, then plunged by 115.58% to -$550.0 in 2023, then surged by 1894.18% to $9868.0 in 2024, then fell by 21.18% to $7778.0 in 2025, then sank by 121.29% to -$1656.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$1656.0, $7778.0, and -$760.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 65.20 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 171.00 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -264.59 Mn |
| 10 | HeartSciences | 6.20 Mn | 4.50 Mn | - | -1,656.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1,656.00 |
| Apr 30, 2026 | -1,656.00 |
| Oct 31, 2025 | 7,778.00 |
| Oct 31, 2025 | 7,778.00 |
| Jul 31, 2025 | -760.00 |
| Jul 31, 2025 | -760.00 |
| Apr 30, 2025 | -1,880.00 |
| Apr 30, 2025 | -1,880.00 |
| Jan 31, 2025 | -760.00 |
| Jan 31, 2025 | -760.00 |
| Oct 31, 2024 | 9,868.00 |
| Oct 31, 2024 | 9,868.00 |
| Jul 31, 2024 | 13,860.00 |
| Jul 31, 2024 | 13,860.00 |
| Apr 30, 2024 | -41,099.00 |
| Apr 30, 2024 | -41,099.00 |
| Jan 31, 2024 | -4,561.00 |
| Jan 31, 2024 | -4,561.00 |
| Apr 30, 2023 | -550.00 |
| Apr 30, 2023 | -550.00 |